BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,599,000 | -0.4% | 18,634 | -6.7% | 0.21% | -10.0% |
| Q3 2021 | $1,606,000 | -5.7% | 19,967 | -5.6% | 0.23% | 0.0% |
| Q2 2021 | $1,703,000 | -11.2% | 21,157 | -6.9% | 0.23% | -13.3% |
| Q1 2021 | $1,918,000 | -17.8% | 22,734 | -21.8% | 0.26% | -21.9% |
| Q4 2020 | $2,334,000 | -4.0% | 29,081 | -3.8% | 0.34% | -11.1% |
| Q3 2020 | $2,432,000 | -9.6% | 30,239 | -3.2% | 0.38% | -13.4% |
| Q2 2020 | $2,690,000 | +2.1% | 31,243 | -3.7% | 0.44% | -8.7% |
| Q1 2020 | $2,634,000 | -2.3% | 32,440 | +0.7% | 0.48% | +31.8% |
| Q4 2019 | $2,695,000 | -8.6% | 32,226 | -4.4% | 0.36% | -13.9% |
| Q3 2019 | $2,948,000 | +1.5% | 33,706 | -4.9% | 0.42% | +2.4% |
| Q2 2019 | $2,904,000 | -3.3% | 35,460 | -4.0% | 0.41% | +1.5% |
| Q1 2019 | $3,003,000 | +20.2% | 36,937 | -2.6% | 0.41% | +7.9% |
| Q4 2018 | $2,498,000 | -32.4% | 37,942 | -20.8% | 0.38% | -23.9% |
| Q3 2018 | $3,695,000 | -1.5% | 47,925 | -5.6% | 0.50% | -6.4% |
| Q2 2018 | $3,751,000 | -6.3% | 50,789 | -17.5% | 0.53% | -3.8% |
| Q1 2018 | $4,005,000 | -23.3% | 61,574 | -23.8% | 0.55% | -15.3% |
| Q4 2017 | $5,223,000 | -12.8% | 80,800 | -15.4% | 0.65% | -10.7% |
| Q3 2017 | $5,993,000 | +4.0% | 95,513 | +0.3% | 0.73% | +3.0% |
| Q2 2017 | $5,765,000 | +24.0% | 95,232 | +6.2% | 0.71% | +25.0% |
| Q1 2017 | $4,649,000 | +13.9% | 89,636 | -2.7% | 0.57% | +15.2% |
| Q4 2016 | $4,083,000 | -8.9% | 92,093 | -2.2% | 0.49% | -11.8% |
| Q3 2016 | $4,484,000 | +59.4% | 94,201 | +51.5% | 0.56% | +60.8% |
| Q2 2016 | $2,813,000 | +276.6% | 62,194 | +241.8% | 0.35% | +254.1% |
| Q1 2016 | $747,000 | +15.6% | 18,194 | +7.6% | 0.10% | -9.3% |
| Q4 2015 | $646,000 | +5.9% | 16,915 | -9.0% | 0.11% | +1.9% |
| Q3 2015 | $610,000 | -53.8% | 18,579 | -1.5% | 0.11% | -49.8% |
| Q2 2015 | $1,319,000 | +7.1% | 18,871 | +4.9% | 0.21% | +10.5% |
| Q1 2015 | $1,232,000 | +11.3% | 17,992 | +19.2% | 0.19% | +11.0% |
| Q4 2014 | $1,107,000 | +27.8% | 15,097 | +25.1% | 0.17% | +22.9% |
| Q3 2014 | $866,000 | +6.3% | 12,072 | +7.1% | 0.14% | +10.2% |
| Q2 2014 | $815,000 | +208.7% | 11,272 | +214.8% | 0.13% | +195.3% |
| Q1 2014 | $264,000 | +11.9% | 3,581 | +5.4% | 0.04% | +4.9% |
| Q4 2013 | $236,000 | +2.6% | 3,396 | -2.9% | 0.04% | -10.9% |
| Q3 2013 | $230,000 | -5.7% | 3,497 | -0.7% | 0.05% | -6.1% |
| Q2 2013 | $244,000 | – | 3,522 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |